Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 4/20 | 0.58 |
| ▸ | GAA | P10253 | 8/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.50 |
| ▸ | LCT | P09848 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | AGL | P35573 | 1/20 | 0.46 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | UGCG | Q16739 | 1/20 | 0.35 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14624581 | 1.00 | MGAM (0.58) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL2438771 | 1.00 | MGAM (0.58) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL13004948 | 1.00 | MGAM (0.58) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL13848042 | 1.00 | MGAM (0.58) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL4106580 | 1.00 | MGAM (0.58) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL15598932 | 0.97 | MGAM (0.61) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL15593093 | 0.84 | MGAM (0.65) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL19557576 | 0.84 | MGAM (0.65) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL2269497 | 0.82 | MGAM (0.43) | MGAMGAATDP1GBA1LCT | |
| SCHEMBL2430840 | 0.80 | MGAM (0.61) | MGAMGAATDP1GBA1LCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007010266-A1 | PYRROLIDINE COMPOSITIONS | MNL PHARMA LIMITED (GB) | 2007-01-25 | — | — | WO | disclosed |